IP Library Granted Patent US 6,979,459
Granted Patent B1
US 6,979,459 · App. 10/257,037 · Granted Dec 27, 2005

Treatment of skin damage using polyenylphosphatidycholine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,979,459
App. No.
10/257,037
Granted
Dec 27, 2005
Kind
B1
Abstract

Polyenylphosphatidylcholine is topically applied to treat skin damage, such as contact dermatitis (particularly diaper area dermatitis), atopic dermatitis, xerosis, eczema (including severe hand and foot eczema), rosacea, seborrhea, psoriasis, thermal and radiation burns, other types of skin inflammation, and aging. Typical compositions contain from about 0.25% to about 10% of a polyenylphosphatidylcholine preparation obtained form natural sources such as soybean oil which contains at least about 25% by weight, preferably about 40% or more, dilinoeoylphosphatidylcholine.

Claims (20)

1. A topical composition comprising polyenylphosphatidylcholine in a dermatologically acceptable carrier.

2. A composition according to claim 1 wherein dilinoleoylphosphatidylcholine is the most abundant phosphatidylcholine species in the polyenylphosphatidylcholine.

3. A composition according to claim 2 wherein dilinoleoylphosphatidylcholine comprises at least about 25% by weight of the polyenylphosphatidylcholine.

4. A composition according to claim 3 wherein dilinoleoylphosphatidylcholine comprises at least about 40% by weight of the polyenylphosphatidylcholine.

5. A composition according to claim 1 comprising from about 0.25% to about 10% by weight polyenylphosphatidylcholine.

6. A composition according to claim 5 which contains from about 1% to about 7% by weight polyenylphosphatidylcholine.

7. A composition according to claim 6 which contains at least about 40% by weight dilinoleoylphosphatidyl choline in the polyenylphosphatidylcholine.

8. A composition according to claim 1 wherein the polyenylphosphatidylcholine is obtained from soybean oil.

9. A composition according to claim 1 wherein the dermatologically acceptable carrier is an oil-in-water cream.

10. A method for the treatment of skin damage comprising topically applying to the skin a composition containing an effective amount of polyenylphosphatidylcholine.

11. A method according to claim 10 wherein dilinoleoylphosphatidylcholine is the most abundant phosphatidylcholine species in the polyenylphosphatidylcholine component of the composition.

12. A method according to claim 11 wherein dilinoleoylphosphatidylcholine comprises at least about 25% by weight of the polyenylphosphatidylcholine component.

13. A method according to claim 10 wherein the composition comprises from about 0.25% to about 10% by weight polyenylphosphatidylcholine.

14. A method according to claim 13 wherein the composition contains from about 1% to about 7% by weight polyenylphosphatidylcholine.

15. A method according to claim 13 wherein the composition contains at least about 40% by weight dilinoleoylphosphatidyl choline in the polyenylphosphatidylcholine.

16. A method according to claim 13 wherein the polyenylphosphatidylcholine is obtained from soybean oil.

17. A method according to claim 11 wherein the composition contains an adjunct ingredient selected from the group consisting of α-hydroxy acid, a fatty acid ester of ascorbic acid, and mixtures thereof.

18. A method according to claim 10 wherein the skin damage is selected from the group consisting of eczema, atopic dermatitis, contact dermatitis, seborrhea, xerosis, rosacea, thermal or radiation burns, and psoriasis.

19. A method according to claim 18 wherein the contact dermatitis is diaper area dermatitis.

20. A method according to claim 10 wherein the skin damage is inflammation or aging.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2015
From: N.V. PERRICONE LLC
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT
Reel/Frame 035833/0948 →
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2015
From: MUFG UNION BANK, N.A., AS AGENT FORMERLY KNOWN AS UNION BANK OF CALIFORNIA, N.A., AS AGENT
To: N.V. PERRICONE LLC
Reel/Frame 035835/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2007
From: PERRICONE, NICHOLAS V.
To: N. V. PERRICONE LLC
Reel/Frame 018837/0240 →
SECURITY AGREEMENT Recorded Mar 6, 2006
From: N.V. PERRICONE LLC
To: UNION BANK OF CALIFORNIA, N.A., AS AGENT FOR THE LENDERS
Reel/Frame 017251/0780 →
Continuity (1)
Continuation In Part 0954394700 · Apr 6, 2000